Escient Pharmaceuticals

Escient Pharmaceuticals is a private biotechnology company dedicated to developing first-class G protein-coupled receptor (GPCR)-targeted drugs to address significant and unmet medical needs across a wide range of therapeutic indications. Escient Pharmaceuticals is committed to unlocking the therapeutic potential of specific orphan GPCRs, including the new family of Mas-related G protein receptors (Mrgprs), and will pursue drugs for treating neuroimmune inflammation and autoreactive diseases.